Actively Recruiting
Mucosal and Microbiota Changes During Acute Campylobacteriosis
Led by Mayo Clinic · Updated on 2025-07-28
150
Participants Needed
1
Research Sites
604 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Gastrointestinal (GI) infection with Campylobacter causes inflammation in the bowel and can change bacteria in the gut. Certain individuals with Campylobacter infection are also known to develop chronic bowel problems such as Irritable Bowel Syndrome (IBS). The researchers are doing this study to understand if changes in gut bacteria and gut mucosal lining during an acute infection can help identify individuals who might be at risk for developing problems in the future.
CONDITIONS
Official Title
Mucosal and Microbiota Changes During Acute Campylobacteriosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- No abdominal surgery except appendectomy and cholecystectomy
- Stool culture or Polymerase chain reaction (PCR) positive enteritis with Campylobacter
- Age between 18 and 80 years
You will not qualify if you...
- History of Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (Crohn's disease or ulcerative colitis), microscopic colitis, or celiac disease
- History of gastroenteritis within six months prior to Campylobacter enteritis
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55902
Actively Recruiting
Research Team
M
Margaret K Breen-Lyles, BS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here